Agomab Therapeutics NV
Filer record as of 2026-09-11. Source: SEC EDGAR
- Business address
- POSTHOFLEI 1/6, ANTWERPEN, 2600
- Category
- Non-accelerated filer<br>Emerging growth company
- Cik
- 2020932
- Edgar url
- https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2020932
- Entity type
- other
- Exchanges
- Nasdaq
- Fiscal year end
- 1231
- Name
- Agomab Therapeutics NV
- Sic
- 2836
- Sic description
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- C9
- Tickers
- AGMB
Filings
- Agomab Therapeutics NV 6-K filed 2026-09-14 2026-09-14, 6-K
- Agomab Therapeutics NV 6-K filed 2026-09-11 2026-09-11, 6-K